Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Primary Progressive Multiple Sclerosis With Acute Neurologic Deterioration Secondary to Metabolic Derangements and Medication Effects.
Data Quality in the ProVal-MS Study: Challenges and Lessons Learned.
Activin A in the central nervous system: Mechanistic and therapeutic insights unveiled by emerging technologies.
Microenvironmental Regulation of Central Nervous System Myelination and Remyelination.
Comparative analysis of Antigliotic Guiding Regenerative Gel (AGRG - LDP-916) for peripheral nerve reconstruction: Evidence from prospective randomized controlled studies.
Mechanisms and therapeutic advances of gut metabolites in the regulation of neuroimmune inflammatory diseases.
Modulation of the immunological and neuroinflammatory microenvironment in older people with multiple sclerosis.
FGF17 synergistically targets neuronal survival and oligodendrogenesis to restore stroke deficits.
Teaching NeuroImage: MYRF-Related Mild Encephalopathy With Reversible Myelin Vacuolization.
Endogenous Activation of mGlu5 Metabotropic Glutamate Receptors Is Required for Oligodendrocyte Maturation and Myelinogenesis in Mice.
Wernicke's encephalopathy in mixed connective tissue disease triggered by persistent vomiting: a case report and literature review.
Globoid cell leukodystrophy (Krabbe disease).
Clinical features of older MS patients with and without Alzheimer disease biomarkers.
Family planning and multiple sclerosis - Part 1: Patient perspectives on treatment choices in Sweden.
GLP-1 receptor agonists, metabolic syndrome, and Alzheimer's disease: Lessons and opportunities from the EVOKE trials.
Pyroptosis in Alzheimer's disease: Mechanisms and neuroinflammatory networks.
Response to correspondence: Should autologous HSCT be a first-line option in highly active MS? No.
Alzheimer's disease polygenic risk score associates with hippocampal subfield atrophy and immune-related genetic mechanism.
FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures presenting with postictal purpura and rhabdomyolysis: a case report.
Imposters in the MS clinic: Adult-onset inherited white matter disorders.
Metabolic and skeletal muscle dysfunctions correlate with fatigue behavior in an animal model of multiple sclerosis.
Extracellular Vesicle-Associated miRNA in Multiple Sclerosis Subtypes: Differential Profiles in Secondary Progressive Disease and the Effect of One-Year Siponimod Treatment.
Fatigue and contributing factors in relapsing-remitting multiple sclerosis: a descriptive study based on the comprehensive fatigue assessment battery for multiple sclerosis (CFAB-MS).
Infectious optic neuropathy: the interplay between pathogens and the host immune system-a review of diagnostic and therapeutic dilemmas.
Immunomodulatory and anti-inflammatory potential of S-nitrosoglutathione (GSNO) in multiple sclerosis: a review of mechanisms and therapeutic perspectives.
Pages
« first
‹ previous
…
1078
1079
1080
1081
1082
1083
1084
1085
1086
…
next ›
last »